Corporate information
Registration country
Company type
Venture capital fund investing in biopharmaceuticals and medical technologyFund terms
Fund manager
Fund type
Funding rounds
Fund Closing USD 697,000,000
USD 697,000,000
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
ATP Private Equity Partners III K/S | USD 15,000,000 (USD 15,000,000) |
Investment activity status
Active investor
Selected investments
Displaying 1 - 5 of 5| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Ophthotech Corp | Clinical-stage biotechnology company, engages in developing and commercializing therapies for wet and dry age-related macular degeneration. | N/A | |||
|
|
SFJ Phamaceuticals Inc | A specialty pharmaceutical company, engages in the clinical development and registration of pharmaceutical products in Japan. | N/A | |||
|
|
TetraLogic Pharmaceuticals | A leader in the discovery and development of small molecule drugs called Smac mimetics for the treatment of cancers. | Series C | |||
|
Neomend Inc | A biomedical device company, engages in the development and commercialization of surgical wound healing products | Series D | |||
|
Restoration Robotics Inc | N/A |